In this article, I will go through the weekly dividend
increases and cuts in popular and well-known stocks. (Member of The Dividend
Champions or Canadian All-Star list)
Recently, 11 companies announced dividend increases. Note
that no dividend cuts or suspensions were announced during this period. This is
the first part of the week’s notifications.
A number of other equities analysts have also recently issued
reports on TFII. Susquehanna initiated coverage on TFI International in a
report on Thursday, December 9th. They issued a “positive” rating and a $132.00
target price on the stock. Susquehanna Bancshares began coverage on shares of
TFI International in a report on Thursday, December 9th. They issued a
“positive” rating and a $132.00 target price for the company. Desjardins
boosted their price target on shares of TFI International from C$161.00 to
C$173.00 in a report on Thursday, February 10th. Morgan Stanley raised their
price objective on shares of TFI International from $125.00 to $135.00 and gave
the stock an “overweight” rating in a research note on Wednesday, February 9th.
Finally, TD Securities raised shares of TFI International from a “hold” rating
to a “buy” rating and increased their price target for the stock from $145.00
to $160.00 in a research report on Wednesday, February 9th. Two investment
analysts have rated the stock with a hold rating and fourteen have given a buy
rating to the stock. Based on data from MarketBeat.com, the stock has a
consensus rating of “Buy” and an average price target of $128.92. Read
more …
A number of other equities analysts also recently weighed in
on the stock. Zacks Investment Research downgraded shares of Unilever from a
“hold” rating to a “sell” rating in a research note on Wednesday, February
16th. Societe Generale raised shares of Unilever from a “sell” rating to a
“buy” rating in a research note on Wednesday, January 19th. StockNews.com
downgraded shares of Unilever from a “buy” rating to a “hold” rating in a
research note on Thursday, March 3rd. The Goldman Sachs Group began coverage on
shares of Unilever in a research note on Friday, February 25th. They issued a
“neutral” rating on the stock. Finally, Royal Bank of Canada raised shares of
Unilever from an “underperform” rating to a “sector perform” rating in a
research note on Tuesday, February 15th. Two equities research analysts have
rated the stock with a sell rating, five have assigned a hold rating and one
has issued a buy rating to the company. According to data from MarketBeat.com,
the stock has an average rating of “Hold” and a consensus target price of
$61.51. Read
more …
Other equities research analysts have also issued reports
about the stock. William Blair reaffirmed a "market perform" rating
on shares of W.W. Grainger in a report on Thursday, February 3rd. Royal Bank of
Canada raised their target price on W.W. Grainger from $392.00 to $432.00 in a
research report on Friday, February 4th. Robert W. Baird increased their price
objective on shares of W.W. Grainger from $525.00 to $560.00 in a report on
Friday, February 4th. Morgan Stanley boosted their price target on shares of
W.W. Grainger from $536.00 to $562.00 and gave the stock an "equal
weight" rating in a research report on Friday, February 4th. Finally,
Zacks Investment Research upgraded W.W. Grainger from a "hold" rating
to a "buy" rating and set a $539.00 price objective for the company
in a research report on Monday, December 13th. Two equities research analysts
have rated the stock with a sell rating, four have given a hold rating and six
have given a buy rating to the company's stock. According to data from
MarketBeat.com, W.W. Grainger has an average rating of "Hold" and an
average price target of $510.55. Read
more …
Other equities research analysts also recently issued
reports about the stock. Scotiabank downgraded shares of Realty Income from a
"sector outperform" rating to a "sector perform" rating in
a research note on Wednesday, December 15th. Morgan Stanley reduced their
target price on shares of Realty Income from $79.00 to $78.00 and set an
"overweight" rating for the company in a report on Thursday, March
3rd. Mizuho reduced their target price on shares of Realty Income from $82.00
to $76.00 in a report on Thursday, January 20th. Finally, TheStreet cut shares
of Realty Income from a "b" rating to a "c+" rating in a
report on Thursday, March 3rd. Three equities research analysts have rated the
stock with a hold rating and five have assigned a buy rating to the company's
stock. Based on data from MarketBeat, Realty Income has an average rating of
"Buy" and a consensus target price of $77.80.
NYSE:O opened at $64.88 on Tuesday. Realty Income has a 12
month low of $61.43 and a 12 month high of $74.60. The firm has a fifty day
simple moving average of $68.06 and a 200-day simple moving average of $69.07.
The company has a current ratio of 1.95, a quick ratio of 1.95 and a
debt-to-equity ratio of 0.61. The company has a market capitalization of $38.36
billion, a P/E ratio of 69.02, a PEG ratio of 3.57 and a beta of 0.79. Read
more …
Other analysts have also issued research reports about the
stock. Credit Suisse Group raised their price objective on shares of Bank of
Montreal from $138.00 to $144.00 and gave the stock an "outperform"
rating in a report on Wednesday, August 25th. CIBC raised their price objective
on shares of Bank of Montreal from $139.00 to $148.00 and gave the stock an
"outperformer" rating in a report on Wednesday, August 25th.
Canaccord Genuity raised their price objective on shares of Bank of Montreal from
C$143.00 to C$149.00 and gave the stock a "buy" rating in a report on
Wednesday, August 25th. BMO Capital Markets raised their price objective on
shares of Bank of Montreal from C$150.00 to C$152.00 and gave the stock a
"buy" rating in a report on Wednesday, August 25th. Finally,
Desjardins raised their price objective on shares of Bank of Montreal from
C$133.00 to C$138.00 and gave the stock a "hold" rating in a report
on Thursday, August 26th. Four analysts have rated the stock with a hold rating
and seven have given a buy rating to the company's stock. According to data
from MarketBeat, the company currently has a consensus rating of
"Buy" and a consensus target price of $142.27. Read
more …
Other analysts also recently issued reports about the
company. Wells Fargo & Company reaffirmed a "buy" rating on
shares of The Southern in a report on Monday, August 2nd. Morgan Stanley
boosted their target price on The Southern from $60.00 to $64.00 and gave the
company an "underweight" rating in a report on Thursday, August 19th.
Barclays boosted their target price on The Southern from $70.00 to $76.00 and
gave the company an "overweight" rating in a report on Tuesday, May
25th. Credit Suisse Group reissued a "buy" rating on shares of The
Southern in a report on Wednesday, May 19th. Finally, Mizuho boosted their
target price on The Southern from $57.00 to $60.00 and gave the company an
"underperform" rating in a report on Monday, August 30th. Three
analysts have rated the stock with a sell rating, one has issued a hold rating
and nine have assigned a buy rating to the company's stock. Based on data from
MarketBeat, the company has an average rating of "Hold" and an
average price target of $68.42. Read
more …
TD has been the topic of several other reports. Zacks
Investment Research cut The Toronto-Dominion Bank from a “hold” rating to a
“sell” rating in a research note on Tuesday. BMO Capital Markets reduced their
price objective on The Toronto-Dominion Bank from C$96.00 to C$94.00 and set a
“market perform” rating on the stock in a research note on Friday, August 27th.
Finally, Scotiabank reduced their price objective on The Toronto-Dominion Bank
from C$95.00 to C$94.00 in a research note on Tuesday, August 17th. Four
analysts have rated the stock with a sell rating, four have given a hold rating
and two have assigned a buy rating to the company. Based on data from MarketBeat,
the stock presently has an average rating of “Hold” and a consensus target
price of $80.60. Read
more …
Several other equities analysts also recently commented on
the stock. Royal Bank of Canada upped their price target on shares of Ventas
from $62.00 to $65.00 and gave the company an "outperform" rating in
a report on Wednesday, June 30th. Wolfe Research began coverage on shares of
Ventas in a research note on Monday, June 14th. They issued an
"outperform" rating and a $71.00 target price on the stock. BMO
Capital Markets upgraded shares of Ventas from an "underperform"
rating to a "market perform" rating and set a $60.00 target price on
the stock in a research note on Thursday, August 26th. Robert W. Baird upgraded
shares of Ventas from a "neutral" rating to an "outperform"
rating and set a $58.00 target price on the stock in a research note on Thursday,
May 13th. Finally, Scotiabank upped their target price on shares of Ventas from
$61.00 to $63.00 and gave the stock a "sector perform" rating in a
research note on Thursday, July 1st. Eight equities research analysts have
rated the stock with a hold rating and seven have assigned a buy rating to the
company. Based on data from MarketBeat, the stock has a consensus rating of
"Hold" and a consensus price target of $58.41. Read
more …
One of the main reasons I like blue-chip dividend stocks is
that they’re great for retirement investors. In an era when savings accounts
pay next to nothing, a reliable stream of dividends can go a long way toward
helping folks enjoy their golden years.
One company that has done a fantastic job on the dividend
front is Johnson & Johnson (NYSE:JNJ). In fact, because of JNJ stock’s
strong share-price performance, not only has it provided reliable passive
income, but it has also allowed some investors to retire early. Over the past
20 years, the total return from Johnson & Johnson stock is over 450%.
Obviously, that massive return also means JNJ stock is more
expensive than before. Indeed, from a valuation perspective, Johnson &
Johnson stock isn’t cheap compared to its past or its peers.
But there are still very good reasons to consider JNJ stock
for a retirement portfolio.
First, Johnson & Johnson stock yields 2.4%. That’s not
only better than what you get from any savings account these days, but also
higher than the average dividend yield of all S&P 500 companies, which is
1.3% at the moment. (Source: “S&P 500 Dividend Yield,” multpl.com, last
accessed August 27, 2021.)
Second, JNJ stock pays increasing dividends, so investors
who buy shares today can look forward to earning higher yield on cost in the
years ahead.
Johnson & Johnson (JNJ) is a company that many investors
are likely familiar with. J&J has been in operation for more than 130
years, and has raised its dividend for 58 years in a row. It has one of the
longest and most impressive histories of any dividend growth stock.
J&J is a long-standing member of the Dividend
Aristocrats.
Not only is Johnson & Johnson a Dividend Aristocrat, it
is a Dividend King as well. The Dividend Kings are an even more exclusive group
of stocks, with 50+ years of consecutive dividend increases. There are just 31
companies that have achieved this accomplishment.
J&J has all of the qualities of a great dividend growth
stock. It has a dividend yield above the S&P 500 average, backed by a
strong brand and highly profitable business model, with potential for long-term
growth.
This article will discuss the quintessential Dividend
Aristocrat that is Johnson & Johnson.
J&J is one of the largest companies in the world, but it
started from very humble beginnings. It was founded all the way back in 1886 by
three brothers, Robert, James, and Edward Johnson. In 1888, the three brothers
published a healthcare manuscript titled “Modern Methods of Antiseptic Wound
Treatment”, which would quickly become the leading standard for antiseptic
surgery techniques.
Over the following decades, the company steadily brought new
products to market. Soon, the company was the leading manufacturer across
several healthcare categories, including baby powder, sanitary napkins, dental
floss, and more.
Today, J&J is a global healthcare giant. It has a market
capitalization of $410 billion, and generates annual revenue of more than $81
billion. J&J is a mega-cap stock, a term to describe stocks with market
caps above $200 billion.
